PSG’s PBM Customer Satisfaction Report provides the most in-depth picture of the PBM landscape today, leveraging perspectives taken directly from employer and health plan…
Coronavirus likely to sideline 2020 policy changes for prescription pricing and 340B, while Medicare Part B reimbursement changes continue as planned The coronavirus (COVID-19)…
PLANO, TX – Pharmaceutical Strategies Group (PSG), a leading pharmacy intelligence and technology company providing innovative drug management solutions to hospitals, health systems, health…
PLANO, Texas – Pharmaceutical Strategies Group (PSG), a leading pharmacy intelligence and technology company providing innovative drug management solutions to hospitals, health systems, health…
PLANO, Texas – Pharmaceutical Strategies Group (PSG), a leading pharmacy intelligence and technology company providing innovative drug management solutions to hospitals, health systems, health…
Plan sponsors are concerned about the turbulence in the prescription drug marketplace, particularly the recent alliances between major PBMs and insurers. Since …
The third annual State of Specialty Spend and Trend Report analyzes specialty drug utilization and spending across 36 million pharmacy claims and 73 million…
The Big Three Pharmacy Benefit Managers (OptumRx, Express Scripts, CVS Caremark) released updates to their 2020 formulary exclusions, and our analysis shows that member…
With drug costs continually escalating, health plans need to capture every available dollar to reduce their overall healthcare expenditures. One way to realize value…
When it comes to copay accumulators,patient impact – not final rule – should drive plan sponsor’s strategy As additional guidance is provided, we’ll continue…
